The Internal Revenue Service issued its final regulations on the medical device excise tax (PDF), prompting renewed calls by manufacturers to repeal or delay implementation of the tax.
A provision of the Patient Protection and Affordable Care Act mandates manufacturers pay a 2.3% tax on the sales of certain medical devices starting next month. The tax is considered the industry's contribution to financing the 2010 healthcare law.
Providers and group purchasing organizations have previously raised concerns that manufacturers will pass through the cost of the tax to purchasers of medical devices, while trade groups representing device manufacturers have said the tax will lead to job losses and more broadly will have a negative impact on innovation in the medical technology sector.
In a statement today, the Advanced Medical Technology Association again called for a repeal of the excise tax.